Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Breinig

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Nature Methods|December 19, 2018
Multiplexed orthogonal genome editing and transcriptional activation by Cas12aMarco Breinig, Anabel Y Schweitzer, Anna M Herianto, et al.
Hepatology (Baltimore, Md.)|May 15, 2009
Targeting heat shock protein 90 with non-quinone inhibitors: a novel chemotherapeutic approach in human hepatocellular carcinomaMarco Breinig, Eloisi Caldas-Lopes, Benjamin Goeppert, et al.
Anticancer Research|October 23, 2009
Expression and mutational status of PDGFR in thymic tumoursMichael Meister, Philip Kahl, Thomas Muley, et al.
Genome Medicine|June 17, 2024
Mitoferrin2 is a synthetic lethal target for chromosome 8p deleted cancersStephan Krieg, Thomas Rohde, Tobias Rausch, et al.
The American Journal of Gastroenterology|December 23, 2008
Expression pattern and functional relevance of epidermal growth factor receptor and cyclooxygenase-2: novel chemotherapeutic targets in pancreatic endocrine tumors?Frank Bergmann, Marco Breinig, Michael Höpfner, et al.
Endocrine-Related Cancer|December 24, 2011
Expression and therapeutic relevance of heat-shock protein 90 in pancreatic endocrine tumorsPhilipp Mayer, Andreas Harjung, Marco Breinig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2011
Heat shock protein 90-sheltered overexpression of insulin-like growth factor 1 receptor contributes to malignancy of thymic epithelial tumorsMarco Breinig, Philipp Mayer, Andreas Harjung, et al.
International Journal of Cancer|March 25, 2008
Establishment, characterization and drug sensitivity testing in primary cultures of human thymoma and thymic carcinomaVolker Ehemann, Michael A Kern, Marco Breinig, et al.
Nature Biomedical Engineering|July 28, 2025
Integrated in vivo combinatorial functional genomics and spatial transcriptomics of tumours to decode genotype-to-phenotype relationshipsMarco Breinig, Artem Lomakin, Elyas Heidari, et al.
EMBO Molecular Medicine|February 19, 2015
A high-throughput RNAi screen for detection of immune-checkpoint molecules that mediate tumor resistance to cytotoxic T lymphocytesNisit Khandelwal, Marco Breinig, Tobias Speck, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Nature Methods|December 19, 2018
Multiplexed orthogonal genome editing and transcriptional activation by Cas12aMarco Breinig, Anabel Y Schweitzer, Anna M Herianto, et al.
Hepatology (Baltimore, Md.)|May 15, 2009
Targeting heat shock protein 90 with non-quinone inhibitors: a novel chemotherapeutic approach in human hepatocellular carcinomaMarco Breinig, Eloisi Caldas-Lopes, Benjamin Goeppert, et al.
Anticancer Research|October 23, 2009
Expression and mutational status of PDGFR in thymic tumoursMichael Meister, Philip Kahl, Thomas Muley, et al.
Genome Medicine|June 17, 2024
Mitoferrin2 is a synthetic lethal target for chromosome 8p deleted cancersStephan Krieg, Thomas Rohde, Tobias Rausch, et al.
The American Journal of Gastroenterology|December 23, 2008
Expression pattern and functional relevance of epidermal growth factor receptor and cyclooxygenase-2: novel chemotherapeutic targets in pancreatic endocrine tumors?Frank Bergmann, Marco Breinig, Michael Höpfner, et al.
Endocrine-Related Cancer|December 24, 2011
Expression and therapeutic relevance of heat-shock protein 90 in pancreatic endocrine tumorsPhilipp Mayer, Andreas Harjung, Marco Breinig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2011
Heat shock protein 90-sheltered overexpression of insulin-like growth factor 1 receptor contributes to malignancy of thymic epithelial tumorsMarco Breinig, Philipp Mayer, Andreas Harjung, et al.
International Journal of Cancer|March 25, 2008
Establishment, characterization and drug sensitivity testing in primary cultures of human thymoma and thymic carcinomaVolker Ehemann, Michael A Kern, Marco Breinig, et al.
Nature Biomedical Engineering|July 28, 2025
Integrated in vivo combinatorial functional genomics and spatial transcriptomics of tumours to decode genotype-to-phenotype relationshipsMarco Breinig, Artem Lomakin, Elyas Heidari, et al.
EMBO Molecular Medicine|February 19, 2015
A high-throughput RNAi screen for detection of immune-checkpoint molecules that mediate tumor resistance to cytotoxic T lymphocytesNisit Khandelwal, Marco Breinig, Tobias Speck, et al.
Pageof 3